share_log

澳至尊(2031.HK)新股报告

Australian Supreme (2031.HK) IPO report

羣益證券(香港) ·  Aug 30, 2016 00:00  · Researches

The company is in charge of

(1) the multi-faceted marketing strategy and the sales and distribution network that are closely related to the brand image of "Australia Supreme" establish the market's leading position in the health and personal management product market; (2) enjoy the right of distributor distribution on the basis of reciprocal relationship with collection suppliers; and (3) to manage and sell customers to Hong Kong, rich and able.

Overview of the industry

During the historical recall period, the local demand for health supplements in Hong Kong increased, coupled with the entry of a large number of mainland tourists, retail sales increased from HK $3276.4 in 2010 to HK $4136.0 in 2014.

However, due to the decline in sales of major direct brand brands, the overall health supply market in Hong Kong began to decline in 2013 and 2014. As the USANA brand shifted its focus from Hong Kong to the Chinese market, sales fell sharply in 2013 and 2014. As the company is very heavy in the market, the decline in sales has had a negative impact on retail sales of health products as a whole.

Due to the continued decline in the sales volume of direct shipping services and the shortage of tourists in mainland China, the retail sales plan of Hong Kong's health rechargeable market will continue to decline at the beginning of the testing period. It is expected that direct sales will change at the end of the expected period, while domestic demand will grow slightly, so retail sales of health products will pick up in the expected period.

Milk grass, lemon oil, berries, fullerenes and queen bee products accounted for only 10.4% of the Hong Kong health food market in 2014. However, of the five categories, crude oil accounted for 4.0% of the largest sales in 2014. Milkweed (2.2%), raspberry (2.1%), queen bee (1.0%) and caryophyllene (1.0%). During the expected test period (2015-2019), all five product categories are expected to account for a larger share of the health recharge market. Valuation

According to the IPO price range of HK$0.55 to 0.71, the historical price-to-earnings ratio of Supreme Australia is 33.5-43.5 times, and the price-to-price ratio is about 2.75-2.96 times. A student listed in Hong Kong and involved in a small number of other products

(1112.HK) has a forward price-to-earnings ratio of about 14.9x and a price-to-price ratio of 2.7x; 6893.HK has a historical price-to-earnings ratio of 76.3x and a price-to-price ratio of 4.8x. Since the above shares are not directly comparable to each other, the valuation of Aussie is reliable. The company was listed on the stock market last month due to insufficient international placement, and now it has made a comeback, collecting 40% of the total amount of new shares, and 100% of its new shares have been sold publicly. It is rare in recent years that there is no international placement. All the new shares are open to retail investors, and the lack of big support is skeptical. In addition, the original contractor Shengsheng's capital did not participate in this contract again, and thanks to the American Construction Company, a long-established local brokerage that has always been conservative, it is expected that the opportunity for a substantial increase in trading on the first day will drop sharply, and speculation will be boring; if it is considered in the light of its own basic factors, it is considered that the limit is still too high. Therefore, we propose to maintain the speculative volatility of this stock.

Negative factor

(1) focus mainly on suppliers' supply of well-known health and personal care products, and if there is a shortage or delay in the supply of related products, it may have a significant impact on business and business; (2) rely on the "Organic Nature" brand with HCL license to improve the sales and market awareness of the market. (3) the major supplier may issue a six-month notification agreement to the collection, in which case it may suffer significant adverse effects on business, business conditions and operating conditions; (4) affected by the uncertainty of the Australian market, including inventory of raw material supply and supply, labor cost hikes and Australian dollar rate movements. (5) the main supplier may modify its existing sales or marketing strategy, change its export strategy, reduce its sales or output, change its sales, or appoint other or sub-contractors who may be involved in the market during the market or planning to expand. (6) the degree of responsibility depends on the market acceptability of the brand name "Aojun" and the brand name of the collection products. If the merchant is tainted or invalid or fails to promote it effectively, it may have a significant adverse impact on the business and business.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment